May 2026 $7 M No. 8 $2 to $10 million 56
Consano Medical, Inc.: Raise no. 8, May 2026 × Investors in this round 56 investors had bought by the notice of May 29, 2026: 56 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $7 M offered
Smallest investment taken $1,318
What was sold equity Exemption claimed Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $650,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Khalid Ghafari · Executive Officer · CFO Rich Keenan · Executive Officer · CPO Todd Dunn · Executive Officer · CEO Christopher Dewey · Director Clay Heighten · Director David Matlin · Director Mark Goldwasser · Director Maurice Ferre · Director Mike Stansky · Director Ram Reddy · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Ceros Financial Services, Inc. (CRD 37869) · Rockville, Maryland Sold in all US states Remarks in the notice On the use of proceeds: “Ceros receives a 10% commission for sourcing investors and 5% commission for investors introduce by Potrero Medical, Inc.”Signed by Todd Dunn, Chief Executive Officer. Source: SEC Form D, newest notice filed May 29, 2026. Read the notice at the SEC .
equity SEC Aug 2025 $2 M No. 7 $2 to $10 million 29
Consano Medical, Inc.: Raise no. 7, Aug 2025 × Investors in this round 29 investors had bought by the notice of Sep 2, 2025: 29 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $6 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $500,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Rich Keenan · Executive Officer · Chief Product Officer Todd Dunn · Executive Officer, Director · Chief Executive Officer Chad Zaring · Director Christopher Dewey · Director Mark Goldwasser · Director Maurice Ferre · Director Ramachandra Reddy · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Ceros Financial Services, Inc. (CRD 37869) · Rockville, Maryland Sold in all US states Remarks in the notice On fees: “Ceros receives 10% commission for sourcing investors and 5% commission for investors introduced by Potrero Medical, Inc.”Signed by Todd Dunn, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 2, 2025. Read the notice at the SEC .
equity SEC Oct 2024 $3 M No. 6 $2 to $10 million 6
Consano Medical, Inc.: Raise no. 6, Oct 2024 × Investors in this round 6 investors had bought by the notice of Oct 31, 2024: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $12 M offered; $9 M still to sell
Smallest investment taken $50,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $1,165,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Rich Keenan · Executive Officer · Chief Product Officer Sanjay Banerjee · Executive Officer · Chief Executive Officer Christopher Dewey · Director Mark Goldwasser · Director Maurice Ferre · Director Ramachandra Reddy · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Ceros Financial Services, Inc. (CRD 37869) · Rockville, Maryland Sold in all US states Remarks in the notice On fees: “Ceros receives 10% commission for sourcing investors and 5% commission for investors introduced by Potrero Medical, Inc.”Signed by Sanjay Banerjee, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 31, 2024. Read the notice at the SEC .
equity SEC Mar 2023 $18 M No. 5 $10 to $50 million 99
Consano Medical, Inc.: Raise no. 5, Mar 2023 × Investors in this round 99 investors had bought by the notice of Apr 10, 2023: 99 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $18 M of $25 M offered; $7 M still to sell
Smallest investment taken $1
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $479,996
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Joe Urban · Executive Officer, Director Alan Chesler · Director Andrew Offer · Director Colby Wood · Director Daniel Burnett · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Ceros Financial Services, Inc. (CRD 37869) · Rockville, Maryland Sold in all US states Signed by Joseph Urban, President and CEO. Source: SEC Form D, newest notice filed Apr 10, 2023. Read the notice at the SEC .
equity SEC Jun 2019 $17 M No. 4 $10 to $50 million 26
Consano Medical, Inc.: Raise no. 4, Jun 2019 × Investors in this round 26 investors had bought by the notice of Oct 29, 2019: 26 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $17 M of $20 M offered; $3 M still to sell
Smallest investment taken $1
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Joe H. Urban · Executive Officer, Director Alan Chesler · Director Carter Meyer · Director Daniel Burnett · Director Frederic H. Moll · Director Jay H. Watkins · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Joseph Urban, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Oct 29, 2019. Read the notice at the SEC .
equity SEC May 2018 $25 M No. 3 $10 to $50 million 32
Consano Medical, Inc.: Raise no. 3, May 2018 × Investors in this round 32 investors had bought by the notice of Jul 10, 2018: 32 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $25 M of $31 M offered; $7 M still to sell
Smallest investment taken $1
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Daniel Burnett · Executive Officer, Director Joe Urban · Executive Officer Alan Chesler · Director Carter Meyer · Director David Greenberg · Director George Rapier · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Joseph Urban, President and CEO. Source: SEC Form D, newest notice filed Jul 10, 2018. Read the notice at the SEC .
equity SEC Aug 2016 $7 M No. 2 $2 to $10 million 21
Consano Medical, Inc.: Raise no. 2, Aug 2016 × Investors in this round 21 investors had bought by the notice of Aug 7, 2017: 21 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $12 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Daniel Burnett · Executive Officer, Director Alan Chesler · Director Carter Meyer · Director David Greenberg · Director George Rapier · Director Urban Joe · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Daniel Burnett, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Aug 7, 2017. Read the notice at the SEC .
equity SEC May 2014 $4 M No. 1 $2 to $10 million 9
Consano Medical, Inc.: Raise no. 1, May 2014 × Investors in this round 9 investors had bought by the notice of May 27, 2014: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken $12,500
What was sold equity Exemption claimed Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $272,999
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Daniel Burnett · Executive Officer Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Kevin Farrelly (CRD 5181178) · broker-dealer Gordian Investments, LLC (CRD 158611) · San Francisco, California Sold in all US states Andrew Finnegan (CRD 2709048) · broker-dealer Gordian Investments, LLC (CRD 158611) · San Francisco, California Sold in all US states Aaron Travis (CRD 2440803) · broker-dealer Gordian Investments, LLC (CRD 158611) · San Francisco, California Sold in all US states Ehrenberg Chesler Securities, Inc. (CRD 130790) · broker-dealer Ehrenberg Chesler Securities, Inc. (CRD 108) · San Antonio, Texas Sold in all US states Signed by Daniel Burnett, Ceo. Source: SEC Form D, newest notice filed May 27, 2014. Read the notice at the SEC .
equity SEC